56903-88-9 Usage
Methyl ester derivative
piperazine carboxylic acid The compound is derived from piperazine carboxylic acid by attaching a methyl ester group, which influences its chemical properties and reactivity.
Contains a benzyl group
The presence of a benzyl group (a phenyl ring connected to a methyl group) contributes to the compound's structure and properties, including its potential applications in drug synthesis.
Contains a methyl group
The addition of a methyl group to the piperazine carboxylic acid structure enhances the compound's reactivity and contributes to its potential uses in pharmaceutical applications.
Pharmaceutical industry use
Precursor in drug synthesis 1-Benzyl-4-methyl piperazine-2-Carboxylic acid methyl ester is commonly used as a starting material in the production of various drugs, such as antipsychotic and antidepressant medications.
Psychoactive substance potential
The compound has been studied for its effects on the central nervous system, which may contribute to its potential use in the development of psychoactive substances.
Central nervous system effects
Research has focused on understanding the compound's impact on the central nervous system, which could lead to the development of new treatments for neurological disorders.
Novel treatments for neurological disorders
The compound's potential role in treating neurological disorders is currently being investigated, highlighting its versatility and importance in research and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 56903-88-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,9,0 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 56903-88:
(7*5)+(6*6)+(5*9)+(4*0)+(3*3)+(2*8)+(1*8)=149
149 % 10 = 9
So 56903-88-9 is a valid CAS Registry Number.
56903-88-9Relevant articles and documents
Hybridized and isosteric analogues of N1-acetyl-N4-dimethyl-piperazinium iodide (ADMP) and N1-phenyl-N4-dimethyl-piperazinium iodide (DMPP) with central nicotinic action
Manetti, Dina,Bartolini, Alessandro,Borea, Pier Andrea,Bellucci, Cristina,Dei, Silvia,Ghelardini, Carla,Gualtieri, Fulvio,Romanelli, Maria Novella,Scapecchi, Serena,Teodori, Elisabetta,Varani, Katia
, p. 457 - 465 (2007/10/03)
A series of piperazine derivatives, obtained by hybridization of N1-acetyl-N4-dimethyl-piperazinium iodide (1, ADMP) and N1-phenyl-N4-dimethyl-piperazinium iodide (3, DMPP) or of the corresponding tertiary bases (2, 4) with arecoline (5) and arecolone (6) or by isosteric substitution of the phenyl ring of DMPP, has been synthesized. Hybridization afforded compounds that, both as tertiary bases and as iodomethylates, have no affinity for the nicotinic receptor. On the contrary, isosteric substitution gave compounds that maintain affinity for the receptor; among them, two tertiary bases (37, 38), show affinity in the nanomolar range for the nicotinic receptor. The pharmacological profile of these isomeric compounds is quite interesting as they present differences in their peripheral and central effects, suggesting that they interact with different subtypes of the nicotinic receptor. Copyright (C) 1999 Elsevier Science Ltd.
